Skip to main content
Caplight Logo









Pharma Holdings

Pharma Holdings

Private
OsloHealthcare & Life Scienceshttps://www.pharmaholdings.no/

Last Round

VC Round

Dec 22, 2023

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Pharma Holdings is a clinical-stage pharmaceutical company that develops antimicrobial drugs and treatments for respiratory viral infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial drugvirtual biotechlytic peptidesclinical-stage pharmanasal decolonizationdrug licensingcontract research organizationCROcontract development and manufacturing organizationCDMOantibiotic alternativemembrane-lysingdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharma Holdings Comparables

Compare Pharma Holdings with similar companies based on industry and business-model similarity.

Pharma Holdings comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amprologix
86%
AMR Bio Limited
84%
EMV Capital
80%

Pharma Holdings Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 22, 2023
VC RoundDec 16, 2022
VC RoundFeb 3, 2021

Key People

Founding team and executive leadership

Chris Lütken

CEO

Executive Team

Torsteinn Erlingsson

CFO

Executive Team

Pharma Holdings Investors

Notable investors and investment history

Pharma Holdings investors
InvestorRounds
Picasso VenturesVC Round
AleapVC Round
Norinnova Forvaltning ASVC Round
NOMEVC Round, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 460% MoM.

  • Jul 25, 2026

    Monthly visitors increased 687% MoM, from 31 to 244.

Pharma Holdings Filings

Explore SEC and related filing metadata, where available.

Pharma Holdings filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pharma Holdings's valuation, stock price, and market status.

Is Pharma Holdings a public or private company?

Pharma Holdings is a private company.

What is the current stock price of Pharma Holdings?

Pharma Holdings is a private company with no public stock price. No recent secondary market data is available.

How much is Pharma Holdings worth (valuation)?

Valuation information for Pharma Holdings is not publicly available.

Can I buy Pharma Holdings stock?

Pharma Holdings shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pharma Holdings's last funding round?

Pharma Holdings's most recent funding round was VC Round on December 22, 2023.

Who are the main investors in Pharma Holdings?

Key investors in Pharma Holdings include Picasso Ventures, Aleap, Norinnova Forvaltning AS.

Will Pharma Holdings IPO soon?

No public IPO plans have been announced for Pharma Holdings.

How can I track Pharma Holdings secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pharma Holdings's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range5
Year Founded2017
Last FundingDec 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?